AI Article Synopsis

  • There is no standardized method for evaluating clinical complete response (cCR) in rectal cancer after neoadjuvant chemoradiotherapy (nCRT), leading to confusion with true pathological complete response (pCR).
  • MRI challenges, like tissue edema and fibrosis, along with accuracy issues in endoscopic biopsy, complicate the staging of local lesions post-nCRT.
  • Using transanal multipoint full-layer puncture biopsy (TMFP) could improve cCR assessment by integrating histological criteria, enhancing precision while reducing complications, although more research is necessary.

Article Abstract

There is currently a lack of standardized criteria for evaluating clinical complete response (cCR) in rectal cancer post-neoadjuvant chemoradiotherapy (nCRT), often resulting in discrepancies with true pathological complete response (pCR). Staging local lesions via MRI is challenged by tissue edema and fibrosis post-nCRT, while endoscopic biopsy accuracy is compromised by residual cancer foci in the muscular layer. Transanal local excision offers a relatively accurate assessment of lesion regression but poses challenges including impaired anal function and elevated complication rates. Building on current diagnostic frameworks, we propose enhancing cCR assessment by integrating histological criteria from transanal multipoint full-layer puncture biopsy (TMFP). This approach aims to improve accuracy while minimizing complications, offering promise for patients opting for observation-based treatments. Further research is needed for definitive conclusions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695227PMC
http://dx.doi.org/10.3389/fonc.2024.1428583DOI Listing

Publication Analysis

Top Keywords

complete response
12
clinical complete
8
rectal cancer
8
transanal multipoint
8
multipoint full-layer
8
full-layer puncture
8
puncture biopsy
8
enhancing clinical
4
response assessment
4
assessment rectal
4

Similar Publications

Objective: To explore the safety and efficacy of neoadjuvant chemoradiotherapy (nCRT) combined with a PD-1 antibody in improving complete clinical response (cCR) and organ preservation in patients with ultra-low rectal cancer.

Methods: This was a prospective phase II, single-arm, open-label trial. Patients with confirmed pMMR status T1-3aN0-1M0 retcal adenocarcinoma were included.

View Article and Find Full Text PDF

Miller Fisher syndrome (MFS) is a rare Guillain-Barré syndrome (GBS) variant. The global incidence of GBS is approximately one to two in 100,000 children (aged 0 to 15 years) per year. Miller Fisher syndrome represents a further small subset, with the incidence being one to two in 1,000,000 children.

View Article and Find Full Text PDF

Manganese (Mn)-sensing riboswitches protect bacteria from Mn toxicity by upregulating expression of Mn exporters. The Mn aptamers share key features but diverge in other important elements, including within the metal-binding core. Although X-ray crystal structures of isolated aptamers exist, these structural snapshots lack crucial details about how the aptamer communicates the presence or absence of ligand to the expression platform.

View Article and Find Full Text PDF

Purpose: The purpose of this study was to determine the efficacy and safety of low-dose radiotherapy (LDR) for postoperative local chest wall recurrence of breast cancer.

Methods: The records of 52 patients with postoperative local chest wall recurrent breast cancer treated at our cancer center from January 2019 to December 2022. The t-test was used to compare the means of the LDR group and non LDR group.

View Article and Find Full Text PDF

Background: Transarterial therapy (TAT), bevacizumab (Bev), and immune checkpoint inhibitors (ICIs) have individually exhibited efficacy in treating advanced-stage hepatocellular carcinoma (HCC). This study aimed to assess the efficacy and safety of the combination of these three treatments as a neoadjuvant modality in patients with locally advanced HCC.

Methods: The primary endpoint is overall survival (OS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!